37 results
DFAN14A
KRTX
Karuna Therapeutics Inc
22 Dec 23
Additional proxy materials by non-management
4:36pm
and competitors to the announcement of the proposed acquisition or difficulties in employee retention as a result of the announcement and pendency … of the proposed acquisition or difficulties in employee retention as a result of the announcement and pendency of the proposed acquisition. The actual
DFAN14A
MRTX
Mirati Therapeutics Inc
10 Oct 23
Additional proxy materials by non-management
6:48am
difficulties in employee retention as a result of the announcement and pendency of the proposed acquisition. The actual financial impact … and/or potential difficulties in employee retention as a result of the announcement and pendency of the proposed acquisition. The actual financial impact
SC TO-C
EX-99.3
RYZB
RayzeBio Inc.
26 Dec 23
Information about tender offer
4:22pm
and competitors to the announcement of the proposed acquisition or difficulties in employee retention as a result of the announcement and pendency of the proposed
SC TO-T/A
EX-99
RYZB
RayzeBio Inc.
12 Feb 24
Third party tender offer statement (amended)
7:34am
of the proposed transaction and/or potential difficulties in employee retention as a result of the consummation of the proposed transaction. Forward
SC TO-T/A
EX-99
RYZB
RayzeBio Inc.
23 Feb 24
Third party tender offer statement (amended)
7:34am
to the consummation of the proposed transaction and/or potential difficulties in employee retention as a result of the consummation of the proposed transaction
SC TO-C
EX-99.3
r40pheyuyxwmj
3 Jun 22
Information about tender offer
5:15pm
SC TO-T/A
EX-99
a72g92
19 Jul 22
Third party tender offer statement (amended)
7:13am
8-K
EX-99.1
dlb80 mwbieoa5hj96f
18 Mar 24
Strengthening Neuroscience Portfolio
8:56am
SC TO-C
EX-99.4
snuzr ciukz
26 Dec 23
Information about tender offer
4:22pm
SC TO-T/A
EX-99.1
nlwon 0a1nx7qfx
16 Aug 22
Third party tender offer statement (amended)
7:08am
SC TO-C
EX-99.5
07zv1y0c
26 Dec 23
Information about tender offer
4:22pm
SC TO-C
EX-99.2
nboabc19 aa3
3 Jun 22
Information about tender offer
5:15pm
SC TO-T/A
EX-99
cp6orqczrg aq
17 Nov 20
Third party tender offer statement (amended)
8:33am
SC TO-T/A
EX-99
hjv asydno
4 Nov 20
Third party tender offer statement (amended)
7:01am
SC TO-C
jl9k6x7o
3 Jun 22
Information about tender offer
5:15pm
SC TO-C
hzbvb8
26 Dec 23
Information about tender offer
4:22pm
8-K
z750 5ve7
22 Dec 23
Bristol Myers Squibb Strengthens Neuroscience Portfolio with Acquisition of Karuna Therapeutics
4:15pm
SC TO-C
EX-99.2
dorw6kl
26 Dec 23
Information about tender offer
4:22pm
DFAN14A
37ewetg73
22 Dec 23
Additional proxy materials by non-management
4:21pm
SC TO-C
EX-99.1
ouwqv
26 Dec 23
Information about tender offer
4:22pm